UNMC Eppley Cancer Center Awarded $4.4 Million Grant to Battle Pancreatic Cancer

The University of Nebraska Medical Center and Johns Hopkins

University are the only two institutions in the nation to receive

a Special Programs of Research Excellence (SPORE) grant from the

National Cancer Institute to investigate gastrointestinal cancer.

Through the $4.4 million SPORE grant, basic and clinical

researchers from the UNMC Eppley Cancer Center will collaborate

with peers from Creighton University and the Creighton Cancer

Center to explore new strategies for the prevention, early

detection and treatment of pancreatic cancer.

The UNMC Eppley Cancer Center grant is the only SPORE award to

emphasize research into pancreatic cancer — one of the most

difficult cancers to survive. For all stages of the disease

combined, the one-year survival rate is just 20 percent. The

five-year survival rate is 4 percent.

The cancer is hard to detect because symptoms generally do not

occur until the disease is advanced. Little is known about its

causes, and consequently, how to prevent it. Finally, pancreatic

cancer is aggressive.

Margaret Tempero, M.D., interim director of the UNMC Eppley

Cancer Center, lauded the

potential of the grant. The grant gives researchers freedom in

designing their projects and in use of their money. The grant

also encourages collaboration with other institutions and

initiation of more projects not originally outlined in their

grant application.

"The SPORE grant offers great opportunities and

flexibility," said Dr. Tempero, who also is the chief

investigator of the grant. "The grant allows us to do things

we couldn’t do with other National Institutes of Health

funding. Specifically, it allows us to change directions in our

research

and provides career development funds to attract other

investigators."

Ultimately, the grant is designed to generate further research

ideas.

-over-

"The SPORE grant doesn’t fit the model of typical

research," said Andrew Chiardo, chief of the Organ Systems

Coordinating Branch in the Cancer Therapy, Diagnosis and Centers

Division of the NCI. "Typical research is

hypothesis-testing. SPORE grant research is

hypothesis-generating."

Among the projects funded under the SPORE grant is the

investigation of a new strategy for treating pancreatic cancer.

The therapy is focused on developing antibodies that are

attracted to antigens produced by cancerous tumors, thereby

allowing the antibodies to attack the tumors.

"We’re using biology and traditional therapy,"

Dr. Tempero said. "By attaching a radioactive particle to an

antibody, the antibody serves as a homing device searching for

the tumor-associated antigen and treating the tumor with

radiation."

"Patients with pancreatic cancer have elevated levels of

a hormone called amylin, which is released from the pancreatic

islet cells that make insulin," said Tom Adrian, Ph.D.,

professor of biomedical sciences at Creighton University.

"We will work to identify the cancer cell factor responsible

for increased amylin production and investigate whether this

factor or amylin itself are valuable as early diagnostic

indicators of this devastating cancer."

Other projects funded by the grant include developing and

testing tumor vaccines, examining the formation of pancreatic

tumors and studying the role of smoking in the development of

pancreatic tumors.

In addition, researchers will gather molecular genetic data on

families that show a proclivity toward developing pancreatic

cancer, according to Henry T. Lynch, M.D., director of

Creighton’s Cancer Center and professor and chair of

preventive medicine and public health at Creighton. The group

also will create a national familial pancreatic cancer registry

and will conduct studies on the molecular genetics of the

disease.

UNMC is the only public academic health science center in the

state. Through its commitment to research, education and patient

care, UNMC has established itself as one of the country’s leading

centers for cancer research and treatment and solid organ

transplantation. More than $25 million in research grants and

contracts are awarded to UNMC scientists annually. In addition,

UNMC’s educational programs are responsible for training more

health professionals practicing in Nebraska than any other

institution.